Retrospective measurement of the serum samples for AFP and %AFP-L3 during the antiviral treatment showed nearly all below 10%, which is consistent with AFP elevation due to cirrhosis/ALT flare rather than HCC as shown in Table 2. This evidence concerns the gene AFP and hepatocellular carcinoma.